Agenda

Join us as we  showcase the best of the Rocky Mountain & Southwest Region

in the North Hall of  the Phoenix Convention Center on October 3 & 4, 2018. 

AGENDA

Your White Hat Registration includes admission to the following events PLUS the opportunity to opt-in to the AzBW one-on-one partnering system powered by Jujama.

Share Your Story | Build Your AzBW Schedule | Make Connections | Set Your Meetings

Partnering invitations will be sent to all AzBW registered attendees beginning September 1, 2018.  Attendees who opt-in to the system will have the opportunity to schedule meetings from October 1 - October 5, 2018 based on their schedule in the system.

Wednesday, October 3, 2018

 AZBio Awards Celebration

Meet the researchers, entrepreneurs, leaders, and team members who are at the heart of life-changing and life-saving innovations.

3:00 PM  - Registration and Cocktail Bar Opens

4:00 PM to 5:30 PM – AZBio Award Ceremony Theater Style!

5:30 PM – 8:30 PM  - FIESTA! 

Note:  The Awards Festivities and presentations will begin at 4:00 PM sharp.

Celebrate with the 2018 Honorees from 5:30 PM – 8:30 PM at the  AZBio Awards Fiesta 

Fun - Food - Great Connections  - Student Discovery Zone - Innovation Showcase and More.  (Yes - There is a bar!)

Business Attire is recommended.  Student Posters and Showcase Booths must be set up by 3 PM.

Click here to learn more about the AZBio Awards

 

Thursday, October 4, 2018

White Hat Investors 

In addition to great company presentations in the areas of Medical Device, Diagnostics, Therapeutics and Health IT, White Hat includes general sessions  featuring panel discussions on unique facets of the innovation landscape.

7:30 a.m. Registration Opens

8:30 a.m. Opening General Session 

Opening Keynote - To Be Announced

Panel - Working with Family Offices

Christopher de Souza, PhD, MBA, is a Director at Broadview Ventures. He brings to this role over 20 years experience in cardiovascular and metabolic related biopharmaceutical R&D, corporate strategy and business development. Broadview’s mission is to accelerate the development of promising technology for the diagnosis and treatment of cardiovascular and neurovascular disease through targeted investments. The mission and structure of Broadview Ventures can be traced to the Leducq Foundation and its supporting trust, created in 1996 by French entrepreneur and industrialist Jean Leducq, together with his wife Sylviane. 

Eugene Durenard, PhD serves as the Managing Director of the Stetson Family Office.  Eugene brings a deep expertise in  multi-asset class investment and the entrepreneurial experience spanning 20 years.  A third and fourth generation company focused on philanthropy, Stetson Family Office has formed two foundations – Essentials in Education (EIE) and Healthcare Impact Foundation (HCIF).  Stetson Family Office also manages money for separate accounts in private equity.

9:30 a.m. Innovator Breakout Tracks

Presentations featuring the top companies from across the Rocky Mountain Southwest Region

  • Room 221:  The presenting company schedule will be announced in September, 2018
  • Room 222:  The presenting company schedule will be announced in September, 2018

10:30 a.m. General Session Panel

 Bridging the Funding Gap

Igor DaCruz is a Senior Vice President for Silicon Valley Bank. He leads the Biotech and Diagnostics practice for the Southwest geography, including AZ. His specialties include provide financial solutions for high growth public and private life science companies with a focus in venture debt. For 35 years, SVB has helped innovative companies and their investors move bold ideas forward, fast. SVB provides targeted financial services and expertise through its offices in innovation centers around the world. With commercial, international and private banking services, SVB helps address the unique needs of innovators. Learn more at www.svb.com.

Rosemarie Truman is Founder and CEO of the Center for Advancing Innovation (CAI), a 501c3 non-profit with a mission to identify breakthrough inventions and maximize their commercial potential. With over 25 years of experience in entrepreneurship, executive leadership, and philanthropy, Rosemarie’s specialty is venture investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries.

Russ Yelton currently serves as Chair of the AZ-HCIF  Trustees; President of Yelton Associates;  Board Member  at Pinnacle Transplant Technologies, Inc. where he previously served at CEO; Member of the Arizona Bioscience Roadmap Steering Committee; a member of the Phoenix Forward Bioscience Leadership Council; and Past-Chair at AZBio.  A leader in Arizona's  Bioscience and Business communities,  Russ served as CEO of Pinnacle Transplant (2014-2017), is a past Board Member of the National Business Incubation Association; and is nationally recognized for his expertise in the business acceleration and incubation sector.  

11:00 a.m. Innovator Breakout Tracks

Presentations featuring the top companies from across the Rocky Mountain Southwest Region

  • Room 221:  The presenting company schedule will be announced in September, 2018
  • Room 222:   The presenting company schedule will be announced in September, 2018

NOON     Lunch General Session with Keynote 

Speaker - To Be Announced

1:00 p.m. Innovator Breakout Tracks

Presentations featuring the top companies from across the Rocky Mountain Southwest Region

  • Room 221:  The presenting company schedule will be announced in September, 2018
  • Room 222: The presenting company schedule will be announced in September, 2018

2:00 p.m.  General Session Panel

Patient Driven Innovation and Investing

Tammy Crawford is the  Founder and Executive Director of Focus on Lyme and leads the team in achieving its mission to improve diagnostics, treatment, prevention, and advocacy for patients suffering from Lyme and associated tick-borne disease.  Tammy was inspired to create Focus on Lyme by her daughter Jessica’s journey and is motivated every day to try to ensure no one has to experience what she did.

 

 3:00 p.mInnovator Breakout Tracks

Presentations featuring the top companies from across the Rocky Mountain Southwest Region

  • Room 221:  The presenting company schedule will be announced in September, 2018
  • Room 222: The presenting company schedule will be announced in September, 2018

4:00 PM  Closing Session- Calimmune - A case study from the innovator and investor perspective

Calimmune, Inc. (acquired by CSL Limited in 2017) is being honored as the 2018 Arizona Bioscience  Company of the Year.  

Louis Breton is the CEO, ARC Technologies Consulting and co-founded Calimmune.  He served as CEO of Calimmune from 2007 up until its acquisition by CSL Limited  in 2017.  Prior to Calimmune, co-founded CellzDirect and served as CEO, EVP and Board Member. CellzDirect was acquired by Invitrogen in 2008.

Harry George  has more than 35 years experience in founding, operating and investing in successful rapid growth technology-related companies.  He is a co-founder of  Solstice Capital.  The first Solstice fund, formed in 1995, invested in 21 portfolio companies.  In July 2001, Solstice Capital formed Solstice Capital II Limited Partnership, a $62 million early-stage venture fund, which has invested in 24 companies.  Solstice Capital currently has $85 million of capital under management. Previously, from 1981 to 1989, Harry was co-founder, Director, and Vice-President of Finance for Interleaf Inc.  During this time, Interleaf, a pioneer in electronic publishing, grew to be a publicly traded company with $100 million in annual revenue.  In January 2000, Interleaf was acquired by Broadvision in a stock merger that valued Interleaf at approximately $1 billion.  Prior to this, Harry was a co-founder, Director and Vice President of Finance of Kurzweil Computer Products, subsequently purchased by Xerox Imaging Systems.  

 

5:00 p.m.  Closing Cocktail Reception 

6:30 PM  Event Concludes